Cytokine therapy in metastatic renal cancer [5] (multiple letters)

New England Journal of Medicine

Volumn 339, Issue 12, 1998, Pages 849-851

  Stadler, W M ^a   Vogelzang, N J ^a   Jerian, S ^a   Keegan, P ^a   Siegel, J ^a   Davis, I D ^a   Gleave, M ^a   Elhilali, M ^a   Negrier, S ^a   Lasset, C ^a   Escudier, B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; PLACEBO; RECOMBINANT GAMMA INTERFERON;

CANCER IMMUNOTHERAPY; CANCER REGRESSION; CLINICAL TRIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; KIDNEY CANCER; LETTER; METASTASIS; PRIORITY JOURNAL; TREATMENT OUTCOME; DISEASE COURSE; KIDNEY CARCINOMA; KIDNEY TUMOR; NOTE; PATHOLOGY; REMISSION; DRUG ADMINISTRATION; DRUG COMBINATION;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; HUMANS; INTERFERON-GAMMA, RECOMBINANT; KIDNEY NEOPLASMS; REMISSION, SPONTANEOUS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; INTERFERON ALFA-2A; INTERLEUKIN-2;

EID: 0032541539     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199809173391217     Document Type: Letter

References (0)